Botanix Pharmaceuticals Ltd (ASX: BOT) - Share Price

- Current share price for BOT : $0.026

Botanix Pharmaceuticals Limited (BOT), an ASX-listed company, is a dermatology company headquartered in Philadelphia and Phoenix (US). The company has received FDA approval for its lead product, Sofdra, for the treatment of primary axillary hyperhidrosis. Sofdra is the first and only new chemical entity approved by the FDA for this condition, offering a novel solution that combines safety and effectiveness for patients who previously lacked treatment options for this socially challenging medical disorder.

BOT General Information ⁺

ASX Code	BOT
Website	http://www.botanixpharma.com
Industry/Sector	Pharmaceuticals
Market Cap ($M)	71
BOT Share Price	$0.026
Day High	$0.026
Day Low	$0.024
Last Close	$0.026
BOT Share Price Movement	- ( No change )

Prices as at 16:40, 20 Jul 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Botanix Pharmaceuticals Ltd (BOT) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield

See all dividends from Botanix Pharmaceuticals Ltd (BOT) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Botanix Pharmaceuticals Ltd (BOT) price-sensitive announcements

BOT - Notice of Allowance for US patent on Sofdra drug substance

Botanix Pharmaceuticals Ltd has received a Notice of Allowance from the United States Pate

Botanix Pharmaceuticals Ltd (BOT)
13 Jul 2026 | 9:13 AM

BOT - Intention to Grant a European patent on Sofdra applicator

Botanix Pharmaceuticals Ltd, a dermatology company based in Philadelphia and Phoenix, anno

Botanix Pharmaceuticals Ltd (BOT)
7 Jul 2026 | 9:14 AM

BOT - Botanix Quarterly Activities Report and Appendix 4C Q3 FY26

In the third quarter of FY26, Botanix Pharmaceuticals Ltd reported notable developments in

Botanix Pharmaceuticals Ltd (BOT)
29 Apr 2026 | 8:50 AM

BOT - Botanix reaches term sheet agreement with 2nd API supplier

Botanix Pharmaceuticals Ltd has announced a term sheet agreement with PPL Pharma Solutions

Botanix Pharmaceuticals Ltd (BOT)
16 Apr 2026 | 8:51 AM

Botanix Pharmaceuticals Ltd (BOT) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Botanix Pharmaceuticals Ltd (BOT) ORDINARY FULLY PAID	Health Care	$71	Botanix Webinar on 27 July - Registration Information	20 Jul 2026 9:08AM	$0.025	$0.026	risen by 4%
Botanix Pharmaceuticals Ltd (BOT) ORDINARY FULLY PAID	Health Care	$71	Notice of Allowance for US patent on Sofdra drug substance	13 Jul 2026 9:13AM	$0.024	$0.026	risen by 8.33%
Botanix Pharmaceuticals Ltd (BOT) ORDINARY FULLY PAID	Health Care	$71	Intention to Grant a European patent on Sofdra applicator	7 Jul 2026 9:14AM	$0.022	$0.026	risen by 18.18%
Botanix Pharmaceuticals Ltd (BOT) ORDINARY FULLY PAID	Health Care	$71	Application for quotation of securities - BOT	25 May 2026 11:57AM	$0.025	$0.026	risen by 4%
Botanix Pharmaceuticals Ltd (BOT) ORDINARY FULLY PAID	Health Care	$71	Notification of cessation of securities - BOT	21 May 2026 5:27PM	$0.025	$0.026	risen by 4%
Botanix Pharmaceuticals Ltd (BOT) ORDINARY FULLY PAID	Health Care	$71	Application for quotation of securities - BOT	13 May 2026 5:13PM	$0.030	$0.026	fallen by 13.33%

BOT Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	Yield (%)	Franking (%)
2027F	C2	-$1.30	-43.50%	0.00%	0.0%
2026F	C2	-$2.30	-50.90%	0.00%	0.0%
2025A	-$86.40	-$4.70	408.70%	0.00%	0.0%

BOT Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2025 A	2026 F	2027 F	2025 A	2026 F	2027 F	2025 A	2026 F	2027 F
Botanix Pharmaceuticals Ltd (BOT)	$68M	4.0870	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
Clarity Pharmaceuticals Ltd (CU6)	$866M	0.3002	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
Neuren Pharmaceuticals Limited (NEU)	$2,151M	-0.7857	0.0743	1.2000	72.9265	67.8800	30.8545	0.00%	0.00%	0.00%

BOT Market Comparison

	Earnings	P/E Ratio	P/B Ratio	P/E Growth
Company	0.00	0.00	0.63	0.00
Market	0.31	12.90	1.13	0.59
Sector	0.45	28.10	2.50	1.92

BOT Directors

Name	Position	Start Date
Dr Stewart James Washer	Non-Executive Director	21 Feb 2019
Dr H. William Bosch	Non-Executive Director	1 Jul 2016
Mr Daniel Sharp	Non-Executive Director	22 Mar 2022
Dr Patricia Walker	Non-Executive Director	25 Aug 2025
Mr Vincent (Vince) Ippolito	President, Executive Chairman, Executive Director	18 Jul 2019

Botanix Pharmaceuticals Ltd (BOT) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
10 Apr 2026	BOSCH, H. William	Issued	Direct Shares	1,666,667	$0.060	$100,000.020
10 Apr 2026	SHARP, Daniel	Issued	Indirect Shares	833,333	$0.060	$49,999.980
10 Apr 2026	IPPOLITO, Vince	Issued	Indirect Shares	1,666,667	$0.060	$100,000.020

See all changes in directors' interest & trades for Botanix Pharmaceuticals Ltd (BOT) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

BOT Management

Name	Position
Howie McKibbon	Chief Executive Officer
Mr Graeme Morissey	Chief Financial Officer, Australia
Mr Chris Lesovitz	Chief Financial Officer, United States of America
Andrew Bickley	Company Secretary

BOT Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Botanix Pharmaceuticals Ltd (BOT). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
161,925,059 (8.29%)	Insignia Financial Ltd
102,100,000 (5.21%)	Copia Investment Partners Ltd

BOT Calendar of Events

Date	Event
02 March 2027	Report (Interim)
01 March 2027	Report (Interim)
26 February 2027	Report (Interim)
28 August 2026	Report (Annual)
28 August 2026	Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us